- World Pharma News Home » Financial » Novartis to first acquire 25% stake from Nestlé for USD 143.18 per share for USD 11 billion
(a free service delivered by FeedBurner)
Novartis has reached an agreement with Nestlé S.A. providing the right to acquire majority ownership of Alcon Inc. (NYSE: ACL) in two steps and add the world leader in eye care to its diversified portfolio focused on growth areas of healthcare. The transaction's first step to purchase a 25% stake in Alcon from Nestlé for USD 11 billion is expected to be completed in the second half of 2008. The second step provides rights for Novartis to acquire, and Nestlé to sell, the remaining 52% Alcon stake held by Nestlé between January 2010 and July 2011.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments